Research Areas

Today's research for tomorrow's
health breakthroughs

With more than 600 clinical trials completed over three decades, we've been the trusted choice for Phase 1-4 clinical trials involving thousands of participants. Our full-time, dedicated, board-certified investigators work with a team of clinical trial professionals in our state-of-the-art facility to complete studies in a wide range of therapeutic areas. 

Diabetes

Type 1 Diabetes

Medical Devices

High Cholesterol

Weight Loss

Type 2 Diabetes

Low Testosterone

NASH

Early Phase

Vaccines

Ophthalmology

Healthy Normal

Learn more about some of the studies we've completed in a wide range of therapeutic areas.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

A Double-Blind Pilot Dose Ranging Study of an Investigational Medication Taken Once Daily Compared to Placebo and to Lovastatin Taken Once Daily in Patients With Hypercholesterolemia

Hypercholesterolemia

Safety and Efficacy of an investigational medication in Patients with Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin

Type II Diabetes

A Multicenter, Randomized, Double-Blind, Active Controlled Study to Compare the Effect of 52 Weeks Treatment with an investigational medication to Metformin up to 1000 mg bid in Drug Naïve Patients with Type II Diabetes.

Type II Diabetes

Randomized, Comparative Evaluation of the Efficacy and Safety of an Investigational Medication Versus Glipizide in Patients With Non-Insulin Dependent Diabetes Mellitus

Type II Diabetes

Accupril Decision on Pharmacotherapy for Hypertension

Hypertension

Evaluation of an Investigational Medication Versus Placebo for Gallstone Prophylaxis During Very Low Calorie Diet-Induced Rapid Weight Loss

Obesity

A 24-Week Randomized, Double-Blind, Multi-Center, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of an investigational Therapy When Added to Therapy of Patients with Type 2 Diabetes

Type II Diabetes

A Phase II, Double-Blind, Randomized, Placebo-Controlled, Proof-of-Concept Study of the Efficacy, Safety, and Tolerability of Pioglitazone HCL (Actos) in Combination With an investigational medication in Subjects With Type 2 Diabetes

Type II Diabetes

Effects of Mixture Therapies on the Overall Glycemic Control of Patients with Type 2 Diabetes: A Comparison of an investigational medication to Once-Daily Insulin Glargine Plus Lispro

Type II Diabetes

A Placebo Controlled Phase II Study to Evaluate the Efficacy and Safety of Twelve-Week Treatment with Two Different Doses of an investigational medication, in Patients with Type 2 Diabetes Mellitus Treatment With Metformin

Type II Diabetes

A Randomized, Double-Blind, Placebo-Controlled Trial to Assess Safety and Tolerability during Treatment of Type 2 Diabetes with Usual Diabetes Therapy and either investigational medication or Placebo

Type II Diabetes

A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Group Comparison Study to Investigate the Efficacy, Tolerability and Safety of Three Different Doses of an Investigational Medication in Patients With Non-Insulin-Dependent (Type II) Diabetes Mellitus, Treated With Diet Alone

Type II Diabetes

Fifty-Six Week Open Label Study to Investigate the Long-Term Safety and Tolerability of an Investigational Medication in Patients with Non-Insulin Dependent (Type II) Diabetes Mellitus, Treated With Diet Alone

Type II Diabetes

Randomized, Comparative Evaluation of an Investigational Medication Combined With Insulin Versus Insulin Combined With Placebo In The Treatment of Patients With Non-Insulin Dependent Diabetes Mellitus

Type II Diabetes

Randomized Study Comparing Two Dose Levels of an Investigational Medication and Vehicle For An Investigational Topical Gel in the Treatment of Diabetic Patients With Neuropathic Plantar Ulcers

Diabetic Plantar Ulcers

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of an Investigational Medication Compared with Ranitidine and GR88502X for the Prophylaxis of Nonsteroidal Anti-Inflammatory Drug-Associated Gastric or Duodenal Ulcers in Patients with Osteo- or Rheumatoid Arthritis and Without a History of Gastric or Duodenal Ulcers

Gastroenterology

A Double Blind Dose-Ranging Study of an Investigational Medication taken Once Daily Compared to Placebo and to Lovastatin Taken Once Daily in Patients with Hypercholesterolemia

Hypercholesterolemia

Standard Training versus Intensive Training for an investigational medication and device in Insulin-Naïve Patients with Type 2 Diabetes Mellitus

Type II Diabetes

A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of the Addition of an investigational medication to Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Pioglitazone Therapy

Type II Diabetes

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of an investigational medication Monotherapy in Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome

Type II Diabetes

Volunteer to participate in a study

See current studies
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.